Chapter 26: Clinical Biochemistry at the Extremes of Age

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to the Deep Dive.

Today, it is just you, us, and the absolute extremes of human biochemistry.

Yeah, we know exactly why you are tuning in right now.

You are a college student stepping into the world of clinical biochemistry for the very first time, and you are staring down a pretty massive chapter.

Right, Chapter 26 from Clinical Biochemistry and Metabolic Medicine.

It covers metabolic medicine at the extremes of age, meaning neonates and the elderly.

It is a dense amount of material, but you really do not need to panic.

We're going to act as your personal tutors today.

Exactly.

Our goal is to translate these incredibly complex pathways into concepts that actually make sense, rather than just, you know, strings of numbers to memorize.

Okay, let's unpack this.

We are going to follow the exact biochemical flow you need to master.

Which means we will trace how normal developmental physiology leads to specific pathophysiology.

Right, and how those physical changes directly alter laboratory results.

And most importantly, how you as a future clinician will interpret those labs to manage your patients.

No textbook jargon, just the vital cause and effect relationship.

That is the perfect mindset to have.

If you can understand the why behind a biological process, what the actual lab values will become second nature.

So let's start at the very beginning of human life, the neonatal period.

Just to make sure we have our terminology locked in, a premature or preterm baby is born before 37 completed weeks of gestation.

And a neonate is a baby within its first month of life.

A low birth weight baby is under 2 .5 kilograms.

And a very low birth weight baby is under 1 .5 kilograms.

Those weight classifications aren't just trivia, they define an immense clinical challenge right out of the gate.

Consider blood volume.

A healthy adult walks around with about 5 liters of blood, but a 1 kilogram premature infant.

Their total blood volume is only about 90 milliliters.

Wait, that is astonishing, 90 milliliters is roughly the volume of a travel sized bottle of shampoo.

Yeah.

If you need to run a full metabolic panel, how do you even draw blood without accidentally causing severe anemia or volume depletion?

Well, you generally can't use standard venous blood draws.

Clinicians are forced to rely on tiny capillary samples, usually taken by pricking the baby's heel.

Ah, the heel prick.

Right.

Because you are working with such microscopic volumes that can easily be contaminated by tissue fluid, it requires ruthless prioritization.

You have to coordinate tightly with the laboratory to decide which specific biochemical investigations are absolutely critical for that baby's survival today.

Keeping that miniature scale in mind, let's look at renal function.

The chapter notes indicate that a newborn actually has a complete set of nephrons, the filtering units of the kidneys, but they aren't fully mature.

They won't reach full functional maturity until the child is about 2 years old.

This developmental lag dictates the laboratory abnormalities you're going to see.

Right, like the glomerular filtration rate.

Exactly.

A newborn's GFR will actually double in their first two weeks of life simply because blood flow to the kidneys increases dramatically after birth.

Which brings up a really interesting quirk about plasma urea.

In an adult, if the kidneys aren't filtering at full capacity, urea spikes.

But in a neonate, plasma urea is naturally quite low.

Yeah, and the reason why is crucial.

A newborn is in a massive anabolic state.

They are growing at an incredible rate, which means they are hoarding nitrogen to build structural proteins rather than breaking it down into urea waste.

Which is why you have to adjust your clinical radar.

Because urea is naturally suppressed by that rapid growth, if you see a neonate's plasma urea climb above 8 millimoles per liter, alarms should be ringing.

Because it strongly suggests glomerular impairment or severe fluid retention.

Spot on.

What about creatinine?

That's the other classic kidney marker.

Creatinine is tricky in the first few days of life.

At the moment of birth, the baby's plasma creatinine actually mirrors the mother's level.

Usually around 35 micromoles per liter, right?

Right.

It's essentially a snapshot of mom's kidney function, not the baby's.

Over the next few weeks, it drops and then slowly climbs to normal adult levels by about six months.

You cannot rely on a single urea or creatinine test to give you a perfect picture of a neonate's renal health.

Clinical observation is paramount.

Let's shift from filtering fluids to the fluids themselves.

Water and electrolytes.

An adult body is about 60 % water, but a neonate is practically swimming at 80 % water.

What's fascinating here is how rapidly they can lose that fluid through something called insensible water loss.

Evaporation, essentially.

Because neonates have a massive surface area to volume ratio compared to adults.

Furthermore, if they are born before 28 weeks, their epidermis hasn't fully formed and they have almost no insulating subcutaneous fat.

So they are essentially evaporating water straight through their skin.

Precisely.

Because of this, their daily fluid requirement per kilogram of body weight can be up to five times higher than yours or mine.

And the hospital environment can actually make this worse, right?

I mean, the very tools used to keep premature babies alive, like overhead radiant warmers or phototherapy lights,

can increase that evaporative water loss by up to 50%.

It's a huge factor.

If the clinician doesn't maintain high ambient humidity in the incubator, that baby will quickly slide into severe dehydration, followed by circulatory and renal failure.

This extreme fluid volatility brings us directly to electrolytes, specifically sodium and potassium.

In a one kilogram baby, the total body stores of sodium and potassium are microscopic.

We are talking less than 100 millimoles each.

The margin for error is razor thin.

That explains why the capillary heel prick we talked about earlier can actually create false lab alarms.

Ooh, pseudo -hyperkalemia.

Exactly.

If a nurse squeezes the baby's heel too hard to get that tiny blood sample, the physical pressure crushes the local tissue cells.

Since potassium lives inside cells, crushing them spills intracellular potassium into the blood sample.

The lab printout will show a terrifyingly high potassium level, but it's a completely artificial error.

It's a classic trap.

Now for true electrolyte imbalances, you have to look at the maternal -fetal connection and medical interventions.

A baby might show true hyponatremia, dangerously low sodium, if the mother is given a prolonged oxytocin infusion during labor.

Because oxytocin acts as an antidiuretic, causing water retention that dilutes the sodium.

Exactly.

Or on the flip side, hyponatremia, high sodium soot, is very often iatrogenic, meaning we caused it medically.

A clinician might administer too much sodium bicarbonate, or the baby might suffer extreme insensible water loss, where they are evaporating pure water faster than they are losing sodium, concentrating the blood.

You're tracking perfectly.

Let's move deeper into the body.

Lungs, acid -base balance, and the liver.

During a difficult delivery, clinicians can take a fetal scalp capillary blood sample.

If that blood pH drops below 7 .2, it is a definitive biochemical signal of severe fetal distress, and the baby must be delivered urgently.

And if that baby happens to be premature, the biggest immediate threat they face upon delivery is respiratory distress syndrome, or RDS.

This condition is a masterclass in how physiological immaturity cascades into a complex metabolic crisis.

Break that cascade down for us.

What exactly is happening in the lungs to throw the biochemistry into chaos?

Premature infants often haven't developed the specialized pneumocytes that produce surfactant.

Surfactant is a substance that reduces surface tension in the lungs.

Without it, the tiny air sacs, the alveoli, simply collapse and stick together every time the baby exhales.

So the lungs physically cannot stay open.

Right.

Because the lungs are collapsed, the baby cannot exhale carbon dioxide.

CO2 builds up in the blood, creating a primary respiratory acidosis.

Simultaneously, because the alveoli are collapsed, oxygen cannot get into the bloodstream, causing systemic hypoxia.

And here is where the rest of the body pays the price.

Because the blood is starved of oxygen, the baby's tissues are suffocating.

To survive, the cells are forced to switch to anaerobic metabolism -making energy without oxygen.

The byproduct of that emergency backup system is massive amounts of lactic acid.

Which layers a secondary metabolic lactic acidosis right on top of the initial respiratory acidosis.

It is a profoundly dangerous compounding biochemical crisis.

Clinicians counteract this by administering synthetic surfactant directly into the airway and using positive pressure ventilation to physically force the lungs open.

Here's where it gets really interesting.

To monitor if those treatments are working, clinicians use transcutaneous blood gas monitors, which are little sensors placed directly on the baby's skin.

But to get the tiny capillaries in the skin to reflect the true arterial blood gases deep inside the body,

these sensors actively heat the baby's skin to 44 degrees Celsius.

The heat forces massive local vasodilation, essentially arterializing the capillary bit.

It is a brilliant physiological workaround, though nurses have to rotate the sensors every few hours to prevent the baby from suffering thermal burns.

Let's follow the blood from the lungs down to the liver.

A neonatal liver is notoriously sluggish.

This is why a newborn's plasma transaminases, the liver enzymes, can be completely normal even if they are twice as high as the adult upper limit for the first three months.

That sluggish liver perfectly sets the stage for one of the most common visual signs in neonatal medicine, jaundice, or in biochemical terms, hyper bilirubinemia.

Why are newborns so uniquely susceptible to turning yellow?

It is a perfect storm.

First, newborns have a significantly higher red blood cell mass than adults.

Second, those fetal red blood cells have a much shorter lifespan, so they are breaking down and releasing bilirubin at a very high rate.

Third, and most importantly, the liver uses an enzyme system to conjugate that bilirubin, essentially attaching a sugar molecule to it so it becomes water soluble and can be dumped into the gut.

But in a newborn, that conjugation system isn't fully online yet.

So the fat soluble, unconjugated bilirubin just backs up into the bloodstream.

Exactly.

This is physiological jaundice.

It usually appears after the baby is 48 hours old, it peaks and fades over about 10 days, and the bilirubin levels rarely exceed 200 micromoles per liter.

But there is a darker side to this, which is pathological jaundice.

How does a clinician spot the difference?

Timing is your biggest clue.

Pathological jaundice almost always appears in the first 24 hours of life.

It's usually driven by a massive abnormal breakdown of red blood cells.

Like due to a blood -typing compatibility between the mother and fetus, or a severe intra -trotterin infection?

Exactly.

And the danger here is a terrifying condition called connectoris, right?

Yes.

Unconjugated bilirubin is fat soluble.

Normally it binds to albumin proteins in the blood, which keeps it contained.

But if the bilirubin levels skyrocket and overwhelm the albumin's carrying capacity, that free, fat soluble bilirubin will cross the fatty blood -brain barrier.

It physically deposits inside the brain tissue, causing devastating permanent neurological damage or death.

Let's ground this in a clinical scenario from the chapter, case one.

Imagine you are reviewing the chart of a full -term infant.

On day two of life, the baby looks yellow.

Labs show a plasma bilirubin of 182 micromoles per liter, and almost all of it is unconjugated.

You check back on day seven, and it has naturally dropped down to 36.

As a clinician, you can breathe easy here.

Look at the markers.

The jaundice appeared on day two, not day one.

The peak level of 182 is below that dangerous 200 threshold.

It is unconjugated, and it is resolving on its own.

So this is a textbook presentation of physiological jaundice caused by a temporarily immature liver.

Right.

If the levels had pushed into the danger zone, the primary treatment is phototherapy.

Placing the baby under intense blue light physically changes the shape of the bilirubin molecules in the skin so they can be excreted, or, in extreme cases, an exchange transfusion.

But what if the lab results show conjugated bilirubin building up in the blood?

That's table 26 .1 in the text.

That changes the entire diagnostic pathway.

If the bilirubin is already conjugated, it means the liver's enzyme system is working perfectly.

The problem is excretion.

The conjugated waste is trapped and backing up into the blood.

This points to a physical blockage in the bile ducts, like congenital biliary atresia.

And since the pigmented bilirubin isn't making it into the gut, a critical low -tech sign to look for is abnormally pale stools.

Spotting that early is essential because early surgical intervention, like the catecyte procedure to bypass the blockage, can save the liver from cirrhosis.

Very well summarized.

Let's shift from clearing waste to managing fuel.

Glucose metabolism.

During the final 10 weeks of pregnancy, a fetus is frantically laying down liver, glycogen, and adipose tissue to prepare for the energy demands of birth.

Which means a baby born prematurely misses out on that crucial stockpiling phase.

They are born with virtually zero glycogen reserves and very little fat, putting them at extreme risk for profound hypoglycemia.

The critical threshold to commit to memory here is 2 .0 millimoles per liter.

A newborn's blood glucose must be kept above 2 .0 to prevent long -term neurological impairment.

Right.

If they are asymptomatic, just feed the baby.

If they are symptomatic, showing tremors or convulsions, you administer 10 % dextrose -the -fit.

Now there is a fascinating and dangerous paradox when it comes to blood sugar.

You would think a baby born to a diabetic mother with poorly controlled high blood sugar would be perfectly fine, but they are actually at a massive risk for severe hypoglycemia.

It's essentially an insulin hangover.

When the fetus is in the womb, the mother's high blood sugar constantly crosses the placenta.

The fetus's pancreas responds by churning out massive amounts of insulin to handle the sugar load.

But the moment the umbilical cord is cut, that endless supply of maternal sugar vanishes instantly.

However, the baby's hyperactive pancreas is still pumping out huge amounts of insulin.

This mismatch causes the baby's blood sugar to completely crash in the hours after birth.

Beyond maternal factors, box 26 .1 highlights rare inborn errors of metabolism.

These are essentially genetic glitches, where a crucial enzyme in the metabolic assembly line is missing.

Take Von Gierke's disease, for example.

The baby is missing the enzyme glucose 6 -phosphatase.

Without that specific enzyme, the liver can break down glycogen halfway, but it absolutely cannot release the final free glucose into the blood.

The baby will suffer severe fasting hypoglycemia, lactic acidosis, and crucially, their glucose levels will fail to rise after a glucagon injection.

Then there is hereditary fructose intolerance, where the baby lacks fructose 1 -phosphate aldolase.

The fascinating clinical clue here is the timeline.

The baby will be perfectly healthy for months until the parents introduce fruit or sucrose into their diet.

Suddenly they experience severe vomiting and hypoglycemia every time they eat.

Or leucine sensitivity, where the milk protein triggers the baby's pancreas to inappropriately dump insulin in the first six months, dropping their blood sugar.

Let's move to minerals in the thyroid.

How does a neonate manage its bone minerals, like calcium?

While in the womb, active transport across the placenta actively pumps calcium into the fetus, keeping fetal calcium levels even higher than the mother's.

This artificially high calcium level actually suppresses the fetus's own parathyroid gland, putting it to sleep.

So when the baby is born and the placenta is gone, their calcium levels naturally plummet for a few days until their own parathyroid gland wakes up and takes over.

Exactly.

But once again, prematurity creates a crisis.

If a baby is born early, they miss out entirely on the massive accumulation of calcium and phosphate that happens in the third trimester.

This results in the rickets of prematurity.

The baby's bones are starved of minerals, leading to osteopenia, very low phosphate, and skyrocketing alkaline phosphatase as the bone tissue struggles in vain to grow.

Let's tie all these neonatal threads together into one clinical picture with Case 2.

Imagine you are caring for a tiny 900 -gram baby born at just 28 weeks gestation.

Their lab results come back.

Calcium is bottomed out at 1 .80, phosphate is 1 .6, which is normal low for neonate, glucose is dangerously low at 1 .6, and bilirubin is spiking at 1 .59.

This is where you see the grand design of pathophysiology perfectly tie together everything you've learned.

The extreme prematurity caused the hypochemia because the baby missed the third trimester mineral transfer.

It caused the hypoglycaemia because the baby had zero time to store glycogen.

And it caused the jaundice because the liver's conjugation enzymes haven't matured yet.

One physiological root cause, three completely different metabolic crises.

Before we leave the newborns, let's briefly touch on plasma proteins and ammonia.

A healthy newborn relies entirely on maternal IgG antibodies that cross the placenta for immune defense.

Those slowly degrade over a few months as the baby builds its own immune system.

But if you analyze a baby's umbilical cord blood and find elevated levels of IgM… That is a major red flag.

IgM antibodies do not cross the placenta.

If a baby has high IgM, it means their immune system had to fight a war while still inside the womb, signaling a severe interotorin infection like rubella or cytomegalovirus.

And for ammonia, levels above 100 micromoles per liter in a term baby, or 200 in a preterm baby, cause seizures and respiratory alkalosis.

Now let's break down thyroid function, looking at figures 26 .1 and 26 .2.

Immediately after birth, the sheer physical trauma and stress of being born causes a baby's thyroid stimulating hormone, or TSH, to absolutely skyrocket, sometimes hitting 15 times the normal adult limit in the hours after birth.

This physiological reality forced a major change in clinical protocols.

If you screen a baby for congenital hypothyroidism on day one, every single test will look abnormal.

Therefore, the standard neonatal heel prick screening test is deliberately delayed for about a week to let that physiological TSH spike subside.

It completely avoids a tidal wave of false positive diagnoses.

We have spent an incredible amount of time watching metabolic systems turn on and mature.

Now we are going to shift gears entirely and travel to the opposite extreme of human life.

The elderly, broadly defined as patients over 65… The demographic reality is that very soon a quarter of the population will fall into this category.

If we connect this to the bigger picture of clinical medicine, treating geriatric patients requires a fundamental shift in how you interpret data.

You are no longer looking at isolated issues.

You must view their biochemistry through the lens of three overarching themes.

Multiple interacting pathologies, reference ranges that naturally alter with biological aging, and the profound dangers of polypharmacy, meaning patients taking a massive cocktail of different drug interactions.

Right.

We talked about alkaline phosphatase being high in growing babies.

Well, it naturally creeps back up in the elderly due to altered bone turnover rates or conditions like Paget's disease.

But the absolute biggest trap you will face as a clinician revolves around geriatric kidney function.

This is a critical tutoring point you must never forget.

In a frail elderly patient, you might look at their standard lab printout, see their plasma creatinine level, and notice it falls perfectly within the normal healthy reference range.

But their actual kidney function, their estimated GFR, might be in severe, dangerous decline.

How can a lab test essentially lie to you?

Because of where creatinine comes from, creatinine is a waste product generated by muscle mass.

As humans age, we naturally lose significant amounts of skeletal muscle.

Think of it like a car engine.

The kidney is the oil filter, and creatinine is the oil pressure sensor.

If the engine itself physically shrinks by half, the total amount of oil moving through the system drops.

The sensor might read normal for that tiny engine, but it completely masks the fact that the filter is failing.

So a normal creatinine in a frail 85 -year -old is an illusion created by their lack of muscle mass.

It is actively masking severe renal failure.

And this is where polypharmacy becomes deadly.

Clinicians must remember this when prescribing renally excreted drugs.

If a clinician simply glances at that normal creatinine and prescribes a standard adult dose, that drug won't be filtered out.

The half -life will stretch on for days, the medication will build up in the bloodstream, and you will accidentally poison your patient.

Let's cement this with our final clinical scenario, case 3.

You're evaluating an 83 -year -old woman who has been brought in for profound confusion.

She takes 10 different daily medications.

Her labs show an EGFR of 34, which is severely low.

Her alkaline phosphatase is high at 398.

Calcium is low at 1 .90.

Glucose is high at 12 .6.

Her TSH is highly elevated at 11 .9.

This is a textbook demonstration of multiple pathologies.

Let's decode it for you.

The low calcium combined with the high bone alkaline phosphatase strongly suggest osteomalacia.

Her elevated glucose confirms type 2 diabetes.

The low EGFR proves her kidneys are severely impaired.

But what about the confusion?

It is so easy to see an 83 -year -old with cognitive decline and immediately write it off as dementia.

That is the ultimate diagnostic error.

Look at her TSH.

It is highly elevated, pointing directly to primary hypothyroidism.

Severe hypothyroidism can absolutely cause profound confusion in the elderly.

So her dementia -like symptoms are actually a completely treatable biochemical failure.

Exactly.

When assessing dementia in an elderly patient, treatable metabolic causes like hypothyroidism or severe B12 deficiency must always be ruled out first.

Furthermore, consider the extreme risks of polypharmacy here.

She is taking 10 different drugs, her kidneys are failing, and her metabolism is compromised.

The odds that her confusion is partly driven by toxic drug interactions are staggeringly high.

You have done an incredible job today.

We have traversed the entirety of this chapter, moving from the microscopic details of premature neonatal enzymes all the way to the compounding metabolic cascades in the elderly.

You now understand the why behind these lab values, which is exactly what will make you an incredible clinician.

I want to leave you with one final provocative thought to ponder or explore on your own.

We saw how maternal IgG protects the neonate until it degrades, and how diminished muscle mass hides renal failure in the elderly.

Consider how the concept of normal is completely fluid.

How might our understanding of reference ranges shift even further as human life expectancy pushes well past 100?

A brilliant question to leave you with.

From all of us on the Last Minute Lecture team, thank you so much for trusting us with your prep today.

Best of luck on your clinical biochemistry exams, you're going to do great.